Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00061633
Brief Title: Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) (FAST)

First Submitted : May 30, 2003
First Submitted that Met QC Criteria : May 30, 2003
First Posted : June 2, 2003 (Estimate)

Results First Submitted : December 2, 2009
Results First Submitted that Met QC Criteria : December 2, 2009
Results First Posted : January 11, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : January 14, 2019
Last Update Posted : January 16, 2019